Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AI adjuvant therapy
DRUG
2 trials
Sponsors
Tao OUYANG
, Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions
Adjuvant Chemoradiotherapy
Artificial Intelligent
Breast Cancer
Hepatocellular Carcinoma (HCC)
Lenvatinib
Liver Surgery
TACE
Phase 2
Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy
NCT01613560
Tao OUYANG
Breast Cancer
Start: 2012-05-05
End: 2024-12-31
Updated: 2021-11-29
Unknown Phase
Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning
Recruiting
NCT07417800
Second Affiliated Hospital, School of Medicine, Zhejiang University
Adjuvant Chemoradiotherapy, Artificial Intelligent, Hepatocellular Carcinoma (HCC) +3
Start: 2025-11-01
End: 2029-12-01
Target: 11000
Updated: 2026-06-10
Related Papers
Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study.
2022-08-02
11 citations